Year: 2010
Type: dissertation
Study design: Observational Study
Abstract: 1. Background and objectives In former publications, persistent disturbances of vasopressin metabolism have been described in early abstinent patients with alcohol dependence. In addition, there is increased evidence for a pathophysiological role of vasopressin in the presentation of craving. Aim of the present study was to evaluate possible alterations of the promoter-related DNA methylation of the vasopressin precursor gene and to support the results with possible alterations of related mRNA-expression of vasopressin in early alcohol withdrawal. 2. Methods We analyzed blood samples of 57 healthy controls and of 111 patients suffering from alcohol dependence that were admitted for detoxification treatment. Promoter-related DNA methylation and mRNA-expression of the vasopressin gene were assessed using real-time PCR. 3. Results and observations Vasopressin mRNA-expression was not significantly different between patients and controls. However, we found a significantly elevated promoter-related DNA methylation of the vasopressin promoter in patients with alcohol dependence (Mann-Whitney U-test: Z=-2.178, p=0.029). The regression analysis showed no significant association between promoter-related DNA methylation of vasopressin and further clinical parameters, like the extent of craving. 4. Conclusion The findings of the present study show significant alterations of the promoter-related DNA-methylation of the vasopressin precursor gene in patients with alcohol dependence and give further evidence for the presence of epigenetical alterations in alcohol dependence. Further studies focusing on longitudinal changes of epigenetic regulation and gene expression of vasopressin are needed to clarify the pathophysiological role of these findings.
Institution: Friedrich-Alexander-Universität Erlangen-Nürnberg
Language: German
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7028181612
